Morad Ansari,Kamli N W Faour,Akiko Shimamura,Graeme Grimes,Emeline M Kao,Erica R Denhoff,Ana Blatnik,Daniel Ben-Isvy,Lily Wang,Benjamin M Helm,Helen Firth,Amy M Breman,Emilia K Bijlsma,Aiko Iwata-Otsubo,Thomy J L de Ravel,Vincent Fusaro,Alan Fryer,Keith Nykamp,Lara G Stühn,Tobias B Haack,G Christoph Korenke,Panayiotis Constantinou,Kinga M Bujakowska,Karen J Low,Emily Place,Jennifer Humberson,Melanie P Napier,Jessica Hoffman,Jane Juusola,Matthew A Deardorff,Wanqing Shao,Shira Rockowitz,Ian Krantz,Maninder Kaur,Sarah Raible,Sabine Kliesch,Moriel Singer-Berk,Emily Groopman,Stephanie DiTroia,Sonia Ballal,Siddharth Srivastava,Kathrin Rothfelder,Saskia Biskup,Jessica Rzasa,Jennifer Kerkhof,Haley McConkey,Anne O'Donnell-Luria,Bekim Sadikovic,Sarah Hilton,Siddharth Banka,Frank Tüttelmann,Donald Conrad,Michael E Talkowski,David R FitzPatrick,Philip M Boone

Abstract:Heterozygous missense variants and in-frame indels in SMC3 are a cause of Cornelia de Lange syndrome (CdLS), marked by intellectual disability, growth deficiency, and dysmorphism, via an apparent dominant-negative mechanism. However, the spectrum of manifestations associated with SMC3 loss-of-function variants has not been reported, leading to hypotheses of alternative phenotypes or even developmental lethality. We used matchmaking servers, patient registries, and other resources to identify individuals with heterozygous, predicted loss-of-function (pLoF) variants in SMC3, and analyzed population databases to characterize mutational intolerance in this gene. Here, we show that SMC3 behaves as an archetypal haploinsufficient gene: it is highly constrained against pLoF variants, strongly depleted for missense variants, and pLoF variants are associated with a range of developmental phenotypes. Among 13 individuals with SMC3 pLoF variants, phenotypes were variable but coalesced on low growth parameters, developmental delay/intellectual disability, and dysmorphism reminiscent of atypical CdLS. Comparisons to individuals with SMC3 missense/in-frame indel variants demonstrated a milder presentation in pLoF carriers. Furthermore, several individuals harboring pLoF variants in SMC3 were nonpenetrant for growth, developmental, and/or dysmorphic features, some instead having intriguing symptomatologies with rational biological links to SMC3 including bone marrow failure, acute myeloid leukemia, and Coats retinal vasculopathy. Analyses of transcriptomic and epigenetic data suggest that SMC3 pLoF variants reduce SMC3 expression but do not result in a blood DNA methylation signature clustering with that of CdLS, and that the global transcriptional signature of SMC3 loss is model-dependent. Our finding of substantial population-scale LoF intolerance in concert with variable penetrance in subjects with SMC3 pLoF variants expands the scope of cohesinopathies, informs on their allelic architecture, and suggests the existence of additional clearly LoF-constrained genes whose disease links will be confirmed only by multi-layered genomic data paired with careful phenotyping.

A Strong Candidate Gene for Nonsyndromic Intellectual Disability Phenotype: SGSM3

Low-level germline mosaicism of a novel <i>SMARCA2</i> missense variant: Expanding the phenotypic spectrum and mode of genetic transmission

A novel variant in SMG9 causes intellectual disability, confirming a role for nonsense-mediated decay components in neurocognitive development

Novel SNX13 Frameshift Variant in an Individual with Developmental Delay.

Identification of 11 Potentially Relevant Gene Mutations Involved in Growth Retardation, Intellectual Disability, Joint Contracture, and Hepatopathy

A Novel Compound Heterozygous Variant of the SLC12A3 Gene in Gitelman Syndrome Pedigree

Heterozygous loss-of-function SMC3 variants are associated with variable growth and developmental features

A splice acceptor variant in RGS6 associated with intellectual disability, microcephaly, and cataracts disproportionately promotes expression of a subset of RGS6 isoforms

DLG3 Impairment Caused by Missense Variants in Non-Syndromic X-Linked Mental Retardation

Heterozygous loss-of-function SMC3 variants are associated with variable and incompletely penetrant growth and developmental features

Identification of candidate gene FAM183A and novel pathogenic variants in known genes: High genetic heterogeneity for autosomal recessive intellectual disability

Identification and functional characterization of de novo variant in the SYNGAP1 gene causing intellectual disability

Biallelic HMGXB4 loss-of-function variant causes intellectual disability, developmental delay, and dysmorphic features

Strict network analysis of evolutionary conserved and brain-expressed genes reveals new putative candidates implicated in Intellectual Disability and in Global Development Delay

Novel GATAD2B loss-of-function mutations cause intellectual disability in two unrelated cases

A gene for nonsyndromic mental retardation maps to chromosome 3p25-pter

PSMC3 proteasome subunit variants are associated with neurodevelopmental delay and type I interferon production

A New Role for LOC101928437 in Non-Syndromic Intellectual Disability: Findings from a Family-Based Association Test

GATAD2B Gene Microdeletion Causing Intellectual Disability Autosomal Dominant Type 18: Case Report and Review of the Literature

Further expanding the mutational spectrum and investigation of genotype–phenotype correlation in 3M syndrome

The mitochondrial solute carrier SLC25A5 at Xq24 is a novel candidate gene for non-syndromic intellectual disability